Showing results (541-550 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|May 10, 2000
Short-term tumor cell lines from renal cell carcinoma for use as autologous tumor cell vaccines in the treatment of kidney cancerR O Dillman, L D Beutel, A N Cornforth, et al.Cancer Biotherapy & Radiopharmaceuticals|May 10, 2000
Establishment and characterization of colon carcinoma and renal cell carcinoma primary culturesB Trojaneck, S Niemitz, B Micka, et al.Cancer Biotherapy & Radiopharmaceuticals|January 5, 2002
Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinomaG Storto, F Buchegger, R Waibel, et al.Cancer Biotherapy & Radiopharmaceuticals|January 5, 2002
Characterization of human tumor-infiltrating lymphocytes expanded in hollow-fiber bioreactors for immunotherapy of cancerC C Malone, P M Schiltz, A D Mackintosh, et al.Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
As good as it gets--training with Henry Kaplan and Saul Rosenberg during the Stanford studies on Hodgkin's disease and lymphomaE GlatsteinCancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Gene therapy for the treatment of cancerD J Buchsbaum, D T CurielCancer Biotherapy & Radiopharmaceuticals|October 18, 2001
FDG-PET in adrenocortical carcinomaA Becherer, H Vierhapper, C Pötzi, et al.Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL)F Najjar, R Hustinx, G Jerusalem, et al.Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Serum factors attenuating the anti-tumor activity of 5-fluorouracilM Miwa, T Kojima, T NaruseCancer Biotherapy & Radiopharmaceuticals|June 2, 2001
Evaluation on a six-dose treatment of anti CD 20 monoclonal antibody in patients with refractory follicular lymphomaA Avilés, A Talavera, J C Díaz-Maqueo, et al.Pageof 223